Torque teno viruses (TTVs) circulate widely among humans, causing persistent viraemia in healthy individuals. Numerous TTV isolates with high genetic variability have been identified and segregated into 29 species of five major phylogenetic groups. To date, the diversity of TTV sequences, challenges in protein expression and the subsequent lack of serological assays have hampered TTV seroprevalence studies. Moreover, the antigenic relationships of different TTVs and their specific seroprevalences in humans remain unknown. For five TTV strains -belonging to different species of four genogroups -we developed, using recombinant glutathione Stransferase (GST)-fused TTV ORF2 proteins, glutathione-GST capture enzyme immunoassays (EIAs) detecting antibodies towards conformational epitopes. We then analysed serum samples from 178 healthy adults and 108 children; IgG reactivities were observed either towards a single strain or towards multiple strains, which pointed to antigenic distinction of TTV species. The overall seroprevalence for the five TTVs peaked at 43 % (18 of 42) in children 2-4 years of age, subsequently declined, and again reached 42 % (74 of 178) among adults. TTV6 species-specific IgG predominated in children, whereas that for TTV13 predominated in adults. During a 3 year follow-up of the same children, both species-specific seroconversions and seroreversions occurred. This is the first EIA-based study of different TTVs, providing a new approach for seroepidemiology and diagnosis of TTV infections. Our data suggest that different TTVs in humans may differ in antiviral antibody profiles, infection patterns and epidemiology.
INTRODUCTION
Torque teno viruses (TTVs), recently categorized into the genus Alphatorquevirus of the family Anelloviridae (Biagini et al., 2011) , are small, non-enveloped viruses with circular ssDNA genomes. TTVs constitute a vast group of related yet distinct members with a high degree of genetic variability. So far, they have been segregated into five genogroups and 29 species, with .35 % divergence based on ORF1 nucleotide sequences (Biagini, 2009; Biagini et al., 2011) . TTVs infect humans ubiquitously; TTV DNA has been detected in blood from up to 90 % of the general population (Abe et al., 1999; Huang et al., 2001; Kakkola et al., 2004; Simmonds et al., 1999) , and viral DNA is also detectable in various tissues and organs (de Villiers et al., 2002; Kakkola et al., 2004; Maggi et al., 2001; Okamoto et al., 2001) . Although TTV was first identified in a patient with hepatitis of unknown aetiology (Nishizawa et al., 1997) , TTVs seem to be well-adapted in humans, escaping eradication and persisting in the body without unequivocal clinical associations (Okamoto, 2009 ).
The TTV genome comprises a 1.2 kb non-coding region and a 2.6 kb coding region. The latter, from which three mRNAs are transcribed, contains overlapping ORFs encoding six proteins (Qiu et al., 2005) . Although TTV sequences are highly divergent, the splice sites and motifs among various isolates are well-conserved (Peng et al., 2002) , suggesting similarity in protein structure and function. The longest ORF, ORF1, is believed to encode a structural capsid protein that is associated with virus replication Mushahwar et al., 1999) . The ORF2-encoded protein is composed of 200 aa and appears to have phosphatase activity and to suppress the nuclear factor kappa B (NF-kB) pathways, thereby also potentially IP: 54.70.40.11
On: Sun, 16 Dec 2018 02:24:46 regulating both innate and adaptive immunity (Peng et al., 2002; Zheng et al., 2007) .
Thus far, only a few studies have addressed TTV antibodies, by employing methods such as immunoblotting, immunoprecipitation and immunocapture PCR (Handa et al., 2000; Kakkola et al., 2008; Ott et al., 2000; Tsuda et al., 1999 Tsuda et al., , 2001 ). Because of small-sized study groups or methodological limitations, the seroprevalence assessments call for reappraisal. Moreover, the issue of antigenic relatedness among TTVs remains unknown, hampering the disclosure of TTV epidemiology. It would be worthwhile to know whether these viruses share common B-cell epitopes and to assess the seroprevalences of the different TTV species. To this end, we expressed in insect cells recombinant glutathione S-transferase (GST)-fused ORF2 proteins of five TTV strains of different species. Employing these proteins as antigen, we developed GST-capture EIAs, and studied the antigenic relationships of various TTVs as well as their seroprevalences in adults and children.
RESULTS

TTV ORF2 proteins as antigen
ORF2 from five TTV strains -genogroup (Gr) 1 TTV3 HEL32, Gr2 TTV6 LTT6, Gr3a TTV13 3h, Gr3b TTV15 5A, and Gr4 TTV29 ViPi08 -were expressed in insect cells as N-terminal GST-66His-tagged fusion proteins and purified by using Ni-NTA agarose. The purified proteins appeared as 40 kDa bands on SDS-PAGE (Fig. 1) . After alignment by CLUSTAL W v. 2.1, among five ORF2s, the amino acid sequence identities ranged between 39 and 48 %, and the nucleotide sequence identities between 65 and 74 % (Table S1 , available in JGV Online).
Detection of TTV ORF2 seroreactivities in human serum samples
To measure the seroreactivities against TTV ORF2 proteins among the general population, GST-capture EIAs were set up with GST-66His-tagged proteins. The EIA reactivities among children and adults are shown in Fig. 2 . In individual serum samples, ORF2 IgG was detected towards either a single TTV strain or against multiple strains. In all, two serum samples had IgG reacting with four TTVs, 12 with three, 23 with two, and 93 with only one TTV strain. Fig. 3(a) shows five representative serum samples reacting with only one TTV strain; Fig. 3(b) shows six representative serum samples reacting with multiple strains. The results in EIA corresponded to those in immunoblot.
Seroprevalence rates among children and adults
Among 108 initial serum samples from children (median age 1.8 years), 27 (25 %) contained TTV IgG (Table 1 ). In the 3 year follow-up, at a median age of 4.8 years, range 4.0-7.0 years, the seroprevalence increased to 30 %. With each of four strains, the seroprevalences increased: with TTV13 3h by 5 % (from 6 to 11 %), with TTV6 LTT6 by 4 % (from 9 to 13 %), with TTV15 5A by 3 % (from 6 to 9 %), and with TTV29 ViPi08 by 1 % (from 7 to 8 %), whereas the seroprevalence for TTV3 HEL32 decreased from 2 to 1 %. As for age, the overall TTV seroprevalence peaked at 43 % among children aged 2-4 years, followed by a decrease at age 4-7 years (30 %) and a subsequent increase among adults (42 %). Among a group of adults, composed of 104 university students and 74 institute staff members, 37 % of the students and 49 % of the staff members had TTV antibodies. The seroprevalence of each TTV strain except TTV3 HEL32 was uniformly higher in staff than in students. Among all the adults, TTV13 3h showed the highest seroprevalence, compared with TTV6 LTT6 among children. The occurrence of multiple reactivities increased in an agedependent manner, with higher rates among adults than children.
TTV seroconversions and reversions among children during 3 year follow-up
Comparison of TTV IgG results in the initial and 3 year follow-up serum samples revealed both seroconversions and reversions: for the five TTV strains, the seroconversion rates were 0-7 % among the initial seronegative sera and 0-6.5 % among the total number of initial sera, whereas the seroreversion rates were 10-75 % among the initial seropositive sera and 0.9-5.6 % among the total number of initial sera (Table 2 ). Fig. 4 shows representative immunoblot results of children with TTV seroconversions or reversions. Among 18 seroconverters and 10 seroreverters, TTV DNA in the initial and 3 year follow-up serum samples were amplified and viral loads were quantified by a pan-TTV quantitative (q)PCR assay ( Table 3 ). The TTV DNA prevalence among the initial serum samples of these 28 children was 89 % and among the follow-up samples it was 100 % (including borderlines). Of 14 seroconverters initially seronegative for all five TTV strains, 11 had TTV DNA both in the initial and in the 3 year follow-up sera, and three (including borderlines) had TTV DNA only in the follow-up sera. The 10 seroreverters who lost their TTV antibodies during follow-up had TTV DNA in both serum samples; however, loads were slightly lower in the followup than the first samples (Table 3) .
DISCUSSION
To investigate the infection immunology of different TTV species, we developed, for five TTV strains, IgG antibody EIAs based on recombinant GST-fused ORF2 proteins, and studied TTV antigenic relationships as well as seroprevalences in the general population.
Thus far, the diagnosis of TTV infection has been based mainly on detection of viral DNA, with only a few serological studies published. Therefore, we set up ORF2-based EIA in a GST-capture format, introduced by Sehr et al. (2001 Sehr et al. ( , 2002 for diagnosis of human papillomavirus infections. As this format employs microwells precoated with glutathione-casein as capture reagent, which selects soluble GST proteins with a native conformation (Sehr et al., 2001) , it allows detection of conformational ORF2 epitopes.
According to transfection studies, TTV transcripts comprise three major species of mRNA (2.8-3.0 , 1.2 and 1.0 kb) Leppik et al., 2007; Qiu et al., 2005) , of which the longest, encoding both ORF1 and ORF2 proteins, constitutes approximately 60 % of the total RNA (Qiu et al., 2005) . The ORF1 protein product of the largest coding sequence, being the putative capsid protein of TTV, would appear to be a good candidate antigen for serological assays. However, in our previous studies, ORF1 expression did not yield a full-length protein, probably due to a low translation level and degradation (Kakkola et al., 2002 (Kakkola et al., , 2008 Qiu et al., 2005) . Although partial ORF1 expression was successful, purification under native conditions of these poorly soluble proteins turned out to be difficult (our unpublished data). On the other hand, the ORF2 proteins could be strongly expressed in insect cells and easily purified. According to immunoblot studies by Kakkola et al. (2008) , the use of the ORF2 antigen as opposed to the other five TTV proteins enables serodiagnosis of the highest sensitivity, indicating that the ORF2 protein is very antigenic.
TTV seroprevalences with the ORF1 protein have been reported by other groups: Ott et al. (2000) showed the highest detection rate (approx. 100 %) with the C-terminal half of the ORF1 protein of a genotype 1 virus, whereas Handa et al. (2000) , using the N-terminal half of the ORF1 protein as antigen, reported a seroprevalence of 38 %. On the other hand, measuring IgG with an ORF1 genotype 6 (HEL32)-derived antigen, Kakkola et al. (2008) observed much lower seroprevalences with both C-terminal (14 %) and N-terminal (0 %) protein regions, pointing to epidemiological differences between TTV genotypes. Nearly onefifth of the same serum samples exhibited seroreactivities towards the ORF2 protein of a single TTV strain, indicating the absence of antigenic cross-reactivity. As the ORF1 protein (60-80 %) displays a higher amino acid divergence 0 (0) 3 (5) 3 (5) 0 (0) 5 (8) 2 (3) 0 (0) 2 (3) 2-4 years 42 18 (43) 2 (5) 7 (17) 4 (10) 7 (17) 3 (7) 1 (2) 2 (5) 3 (7) Total 108 27 (25) 2 (2) 10 (9) 7 (6) 7 (6) 8 (7) 3 (3) 2 (2) 5 ( 18 (29) 0 (0) 8 (13) 9 (14) 4 (6) 6 (10) 4 (6) 2 (3) 6 (10) 5-7 years 45 14 (31) 1 (2) 6 (13) 3 (7) 6 (13) 3 (7) 3 (7) 1 (2) 4 (9) Total 108 32 (30) 1 (1) 14 (13) 12 (11) 10 (9) 9 (8) 7 (6) 3 (3) 10 (9) Adults: cohort Students 108 40 (37) 6 (6) 7 (6) 18 (17) 15 (14) 6 (6) 8 (7) 3 (3) 11 (10) Staff 70 34 (49) 4 (6) 12 (17) 16 (23) 11 (16) 9 (13) 5 (7) 6 (9) 11 (16) Total 178 74 (42) 10 (6) 19 (11) 34 (19) 26 (15) 15 (8) 13 (7) 9 (5) 22 (12) T. Chen and others than the ORF2 protein (40-60 %), it is plausibly non-crossreactive as well. Recently, porcine serology based on the Torque teno sus virus (TTSuV) ORF1 protein, showed antigenic cross-reactivity between two TTSuV1 genotypes that displayed approximately 50 % amino acid identity, but not between the two species TTSuV1 and TTSuV2, which shared only about 25 % identity (Huang et al., 2012) . As the five TTV strains in our study belong to five different species of four genogroups, one could expect distinct antigenicity among TTVs of different genogroups and species in general. Nevertheless, our findings cannot rule out, or in, the possibility of intra-species cross-reactivity.
The seroprevalence rates of all five TTV strains peaked at the age of 2-4 years, and at a level similar to those among adults. These results comply with previous PCR-based findings, showing that TTV infections prevail in childhood (Kazi et al., 2000; Lin et al., 2002; Toyoda et al., 1999) . However, in contrast to PCR studies showing that almost all children are exposed to anelloviruses within the first 2 years of life (Ninomiya et al., 2008) , less than half of the children in our study had antibodies against one or more of the five TTV strains, in line with the antigenic differences observed, and implying wide circulation of other TTV strains. We observed the highest seroprevalence rates with TTV6 LTT6 (Gr2) in children and TTV13 3h (Gr3a) in adults, this difference being either coincidental or genuinely age-specific. In comparison, PCR studies among adults have revealed TTV Gr1 and Gr3 to be the most prevalent genogroups, and Gr2 to be rare (Biagini et al., 2006; Maggi et al., 2005) . The DNA prevalences of Gr1-5 were 70, 2, 73, 48 and 21 % in a French study, and 34, 2, 24, 2 and 12 % in an Italian study (Biagini et al., 2006; Maggi et al., 2005) . Among adults, we observed higher seroprevalences for the two strains belonging to Gr3 than for the other strains. Of note, these two Gr3 species did not cross-react serologically. Conversely, the seroprevalence of TTV3 HEL32 of Gr1 was fairly low, which might be due to the fact that HEL32 is relatively uncommon in the human population. However, our HEL32 ORF2 seroprevalence of 6 % was lower than that observed previously by immunoblotting (Kakkola et al., 2002 (Kakkola et al., , 2008 . The variance could be due to differences in cohort composition or methodology (possibly including matters dealing with epitope exposition or type; linear vs conformational).
To examine TTV primary infections and antibody longevity, we studied children followed for 3 years on average. Seroconversions occurred, except for TTV3 HEL32, at overall rates of 5-7 % of the initial seronegative sera, whilst a number of children that were initially seropositive for a single strain later acquired multiple-genogroup antibodies. This indicates that the simultaneous presence of several TTV genogroups in the human body (de Villiers et al., 2002; Jelcic et al., 2004; Maggi et al., 2005; Niel et al., 2000; Okamoto et al., 2001) can be due to sequential infections, and that antibodies against certain TTV types are non-protective against others. Interestingly, seroreversions were seen among all TTV strains, at rates of 10-75 % of the initial seropositive children, explaining the lower seroprevalences among children aged 4-7 years. However, this high frequency of reversions might be partly due to the low number of initially seropositive children. TTV species-specific seroprevalence by EIA Interestingly, among the seroreverting children, slight reductions in the viral DNA loads were discernible. Of note, whilst the PCR used in this study amplifies almost all TTV species, it cannot distinguish between the TTV species or even genogroups (Maggi et al., 2001) . In general, the vast heterogeneity of anelloviruses hampers classification of a multitude of novel isolates into species. Furthermore, as TTV classification is based on the ORF1 sequences, our initial attempts to classify all of our TTV sequences and match them with the ORF2 antibody data were concluded to be futile. In all, our TTV DNA prevalence among seroconverted and seroreverted children is in line with those reported in previous studies, showing TTVs to circulate commonly in the general population irrespective of the antiviral antibodies (Handa et al., 2000; Kakkola et al., 2008; Ott et al., 2000) and highlighting the remarkable ability of these viruses to evade immunity.
Altogether, this is the first description of antibody EIAs comparing different TTVs regarding their seroprevalences and antigenic cross-reactivities. The methods described should provide new means for diagnosis and epidemiology of TTV infections. Our serological data point to differences in antiviral antibody profiles, infection patterns and epidemiology between TTV species.
METHODS
Samples. From children aged 1-4 years with recurrent or persistent otitis media undergoing a randomized adenoidectomy trial (Hammarén-Malmi et al., 2005) , initial samples of serum were obtained at a median age of 1.8 years (range 1.0-4.0 years), between March 2001 and December 2002, and follow-up sampling occurred 3.1 years later on average, at a median age of 4.8 years (range 3.9-7.0 years). Altogether, 108 paired sera were available and included in the present study. These samples have previously been studied for polyomavirus primary infections (Chen et al., 2011a, b) .
Voluntary adult serum samples were obtained from 104 university students and 74 staff members of our institute, who were asymptomatic at the time of sampling. Recombinant baculoviruses. Based on pFastBacDual, a modified pFastBac vector containing a GST tag and a 66His tag upstream of the multiple cloning site was constructed for expression of GST66His-tagged proteins in insect cells. The ORF2 coding sequences were amplified from plasmids containing TTV genomic DNA. The study included five strains of different species from four genogroups: Gr1 TTV3 HEL32, Gr2 TTV6 LTT6, Gr3a TTV13 3h, Gr3b TTV15 5A and Gr4 TTV29 ViPi08 (Diniz-Mendes et al., 2004; Kakkola et al., 2002; Niel et al., 2005) . The details of each strain are depicted in Table  S2 ; the primers used to amplify the ORF2 fragments are shown in Table  S3 . The amplified ORF2 fragments were cloned into the modified vectors in frame with the GST-66His ORF and confirmed by sequencing. Recombinant baculoviruses were generated by the Bac-toBac system in accordance with the manufacturer's (Invitrogen) instructions. Briefly, recombinant baculovirus genomic DNA was generated by transformation of vector into Escherichia coli strain DH10Bac containing the Autographa californica nucleopolyhedrovirus parent bacmid, and isolated by alkaline lysis. The recombinant bacmids were transfected into Sf9 cells with Cellfectin (Invitrogen). The recombinant baculovirus was passaged in fresh cells for a high-titre stock.
Protein production and purification. Sf9 cells were infected with recombinant virus at an m.o.i. of 10 and grown in Insect Express medium (Lonza) for 2-3 days at 27 uC. The infected cells were harvested by centrifugation at 1000 g for 5 min, washed once with PBS, and suspended in lysis buffer (10 mM Tris/HCl, pH 8.0; 500 mM NaCl; 1 % Triton) supplemented with a protease inhibitor cocktail (cOmplete, EDTA-free; Roche). After keeping on ice for 10 min, the suspension was sonicated three times for 15 s each on ice, and the lysate was collected by centrifugation at high speed, 13 400 g, for 10 min. The GST-66His-tagged ORF2 proteins were affinitypurified using Ni-NTA Agarose (Qiagen) under native conditions in accordance with the manufacturer's suggested protocol. Protein fractions collected in elution buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, pH 8.0) were finally mixed with an equal volume of glycerol and stored at 220 uC. The purified proteins were checked by SDS-PAGE and the concentrations were measured by the Bradford assay (Bio-Rad). For sequence identity analyses, the ORF1 and ORF2 sequences of five TTV strains were aligned by the online program CLUSTAL W v. 2.1 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Western blotting. For detection of TTV antibodies by immunoblot, 1 mg TTV ORF2 proteins per lane were separated by SDS-PAGE (10 % acrylamide) and transferred onto nitrocellulose membranes (Whatman Protran BA 85), which were blocked in 5 % non-fat milk in Tris-buffered saline with 0.1 % Tween 20 (TBS-T) for 30 min at room temperature. Human serum samples, diluted 1 : 100 or 1 : 50 in 5 % non-fat milk/TBS-T, were kept on the blots overnight at 4 uC.
After washing with TBS-T, blots were treated with peroxidaseconjugated rabbit anti-human IgG (Dako) diluted 1 : 10 000 in 5 % non-fat milk/TBS-T for 1 h at room temperature. After washing, blots were developed using a SuperSignal West Dura extended substrate detection kit (Pierce) and exposed to X-ray film (Fuji Super RX).
GST-capture EIA. Glutathione-casein was produced by cross-linking glutathione to casein (Sigma) as described by Sehr et al. (2001) . To set up a GST-capture EIA, 96-well microtitre wells were coated overnight at 4 uC with 200 ng glutathione-casein per well in 50 mM carbonate buffer, pH 9.6 (Sigma). The next day, 180 ml blocking buffer (0.2 % casein in PBS, 0.05 % Tween 20) was applied for 1 h at 37 uC. After addition of 200 ng purified GST-66His-tagged protein per well for 1 h at room temperature, the wells were post-coated with a sample diluent (Anilabsystems) to reduce non-specific signal. Human serum samples diluted 1 : 50 in blocking buffer were added into plates at 100 ml per well and left for 60 min at room temperature in a rocking (400 r.p.m.) EIA incubator. After washing with PBS with 0.1 % Tween 20, rabbit anti-human IgG-HRP conjugate (Dako), diluted 1 : 2000 in blocking buffer, was added (100 ml), and incubated for 60 min. After washing, o-phenylenediamine and H 2 O 2 were added; 12 min later, the reaction was stopped with 0.5 M H 2 SO 4 and the A 492 values were recorded. For each serum, the background absorbance from a well coated with GST-66His tag was subtracted. The cut-offs for positivity were set at 0.200 absorbance units by visual determination of the beginning of the significant rise of the net absorbance values (Fig. S1 ).
Real-time qPCR. DNA in 200 ml serum was extracted by using a QIAamp DNA Mini kit (Qiagen) according to the manufacturer's instructions. The UTR-based qPCR employed the primers and probe described previously (Maggi et al., 2001) , except that a second reverse primer (59-AGCCCGGCCAGACC-39) was added to increase sensitivity. The reactions were done in a 25 ml format consisting of 16 Maxima Probe qPCR Master Mix (Fermentas), 30 nM ROX passive reference dye, 0.5 mM each primer, 0.4 mM probe and 5 ml template. The qPCR was performed with a Stratagene Mx3005 instrument (Agilent Technologies) with the following cycling program: initial denaturation for 10 min at 95 uC, followed by 45 cycles of 15 s at 95 uC and 1 min at 55 uC. The quantification standard was a plasmid containing the TTV UTR comprising serial dilutions covering 6 log 10 . Water served as a negative control and plasmid template as a positive control. The threshold was 500 copies (ml serum) 21 .
